NAFTA Tribunal Rules Against Challenge to FDA Import Alert, Says Canadian Pharma Co.
A NAFTA arbitration tribunal has rejected claims by a Canadian pharmaceutical exporter that the Food and Drug Administration violated the agreement by restricting imports from two of its facilities, according to a press release from the Canadian company. Apotex says…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
an FDA import alert that prohibited imports from two Apotex facilities in Etobicoke and Signet, Canada “effectively removed Apotex from the U.S. solid-dose drug market for almost two years.” But the NAFTA tribunal found in a still-confidential ruling that the import alerts did not violate NAFTA rules, it said. The ruling will be released after a review to remove confidential information (here), said Apotex.